#AI drug design

AI drug design is drawing increasing attention as startups and investors explore how artificial intelligence can accelerate target discovery, molecule generation, and early-stage drug development. Venture coverage in this area often focuses on emerging companies, funding activity, and the broader shift toward AI tools in life sciences.